Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Biochimica Et Biophysica Acta|July 29, 2014
The unfolded protein response as a target for cancer therapyAnika Nagelkerke, Johan Bussink, Fred C G J Sweep, et al.
The Lancet. Oncology|March 1, 2008
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancerJohan Bussink, Albert J van der Kogel, Johannes H A M Kaanders
Journal of Experimental & Clinical Cancer Research : CR|December 19, 2024
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environmentKris T P M Raaijmakers, Gosse J Adema, Johan Bussink, et al.
Scientific Reports|August 18, 2015
Machine Learning methods for Quantitative Radiomic BiomarkersChintan Parmar, Patrick Grossmann, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCCEva-Leonne Göttgens, Johan Bussink, Marleen Ansems, et al.
Biomarkers in Medicine|July 19, 2019
Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancerAnnemarie Em Post, Johan Bussink, Marcel Smid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Interaction of EGFR with the tumour microenvironment: implications for radiation treatmentMonique M Nijkamp, Paul N Span, Johan Bussink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination TherapyDaan F Boreel, Paul N Span, Sandra Heskamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted ImagingLaura K van Dijk, Otto C Boerman, Johannes H A M Kaanders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivityMarloes Wennemers, Johan Bussink, Nicolai Grebenchtchikov, et al.
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Biochimica Et Biophysica Acta|July 29, 2014
The unfolded protein response as a target for cancer therapyAnika Nagelkerke, Johan Bussink, Fred C G J Sweep, et al.
The Lancet. Oncology|March 1, 2008
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancerJohan Bussink, Albert J van der Kogel, Johannes H A M Kaanders
Journal of Experimental & Clinical Cancer Research : CR|December 19, 2024
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environmentKris T P M Raaijmakers, Gosse J Adema, Johan Bussink, et al.
Scientific Reports|August 18, 2015
Machine Learning methods for Quantitative Radiomic BiomarkersChintan Parmar, Patrick Grossmann, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCCEva-Leonne Göttgens, Johan Bussink, Marleen Ansems, et al.
Biomarkers in Medicine|July 19, 2019
Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancerAnnemarie Em Post, Johan Bussink, Marcel Smid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Interaction of EGFR with the tumour microenvironment: implications for radiation treatmentMonique M Nijkamp, Paul N Span, Johan Bussink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination TherapyDaan F Boreel, Paul N Span, Sandra Heskamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted ImagingLaura K van Dijk, Otto C Boerman, Johannes H A M Kaanders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivityMarloes Wennemers, Johan Bussink, Nicolai Grebenchtchikov, et al.
Pageof 22